Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge
Open Access
- 1 November 2019
- Vol. 37 (47) , 6942-6950
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 29 references indexed in Scilit:
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysVaccine, 2010
- Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus MonkeysClinical and Vaccine Immunology, 2009
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNature Reviews Microbiology, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008
- Sucrose fatty acid sulphate esters as novel vaccine adjuvantVaccine, 2006
- Protective Cytotoxic T-Cell Responses Induced by Venezuelan Equine Encephalitis Virus Replicons Expressing Ebola Virus ProteinsJournal of Virology, 2005
- Ebola virus: from discovery to vaccineNature Reviews Immunology, 2003
- Pathogenesis of Experimental Ebola Virus Infection in Guinea PigsThe Journal of Infectious Diseases, 1999